Rani Therapeutics Holdings, Inc. (RANI)

NASDAQ

$0.78

$-0.00

(-0.26%)

Pre-Market

Rani Therapeutics Holdings, Inc. (RANI) Live Price Chart

Last updated: ⁦2026-10-13 10:32:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Rani Therapeutics Holdings, Inc. (RANI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.78, with a market capitalisation of $92.22M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.45 to $3.87. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$92.22M
Open	$0.78
Day's High	$36.27
Day's Low	$0.39
Previous Close	$0.75
Volume	6.02K
Average Volume	729.04K
P/E Ratio	--
52-Week High	$3.87
52-Week Low	$0.45
Dividend Yield	--
Earnings Date	--

Rani Therapeutics Holdings, Inc. (RANI) Pre-Market Stock Price

Rani Therapeutics Holdings, Inc. (RANI) is trading at $0.78 in pre-market trading as of 2026-10-13 10:23:00, up 3.21% ($0.02) from the previous close of $0.75

Pre-market trading shows how investors are pricing RANI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Rani Therapeutics Holdings, Inc. (RANI) 7-Day Stock Price Change

Over the past seven days, Rani Therapeutics Holdings, Inc. (RANI) moved from $0.81 to $0.78, representing a decline of 4.42% ($0.04).

The stock traded between $0.74 and $0.84 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 473.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

RANI 52-Week Price Position

Position in Range: 9.6%

52W Low$0.45

52W High$3.87

RANI is currently trading at $0.78, placing it 9.6% of the way from its 52-week low of $0.45 to its 52-week high of $3.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rani Therapeutics Holdings, Inc. (RANI)?

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Rani Therapeutics Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	69
Exchange	NASDAQ
Company Website	https://www.ranitherapeutics.com

How to Buy Rani Therapeutics Holdings, Inc. (RANI) Stock on MEXC

Eligible investors can buy real shares of Rani Therapeutics Holdings, Inc. (RANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RANI and Place Your Order

Open the RealStocks trading page and search for RANI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rani Therapeutics Holdings, Inc. (RANI) stock price today?

Rani Therapeutics Holdings, Inc. (RANI) is currently trading at $ 0.78, up 3.21% ($0.02) from the previous close of $ 0.75. Intraday prices update in real time during regular trading hours.

2.Is RANI stock going up or down today?

As of 2026-10-13 10:23:00, RANI is trading at $ 0.78, up 3.21% ($0.02) from its previous close of $ 0.75. The stock has traded between $ 0.39 and $ 36.27 during today’s regular session. Past price movements do not guarantee future results.

3.What is RANI pre-market price?

As of 2026-10-13 10:23:00, RANI is trading at $ 0.78 in pre-market trading, up 3.21% ($0.02) from the previous close of $ 0.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RANI after-hours price?

As of 2026-10-13 10:23:00, RANI is trading at $ 0.78 in after-hours trading, up 3.34% ($0.03) from the regular-session close of $ 0.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RANI stock trading now?

RANI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RANI sit relative to its 52-week high and low?

Over the past 52 weeks, RANI has traded between a low of $ 0.45 and a high of $ 3.87. At $ 0.78, the stock is positioned 9.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rani Therapeutics Holdings, Inc. in?

Rani Therapeutics Holdings, Inc. (RANI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rani Therapeutics Holdings, Inc.'s market capitalisation and where is it listed?

Rani Therapeutics Holdings, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 92.22M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RANI valued in terms of P/E ratio and EPS?

RANI trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.26. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rani Therapeutics Holdings, Inc. pay a dividend?

Rani Therapeutics Holdings, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.